CCP
STJ

Corient Capital Partners’s St Jude Medical STJ Stock Holding History

Corient Capital Partners’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,317
Closed -$266K – 325
2016
Q4 		$266K Buy
3,317
+140
+4% +$11.1K 0.05% 268
2016
Q3 		$253K Buy
+3,177
New +$256K 0.05% 269

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Corient Capital Partners's STJ Position: Q1 2017 in Review

Corient Capital Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,317 shares — an estimated $266K sold.

Corient Capital Partners first reported a position in STJ in Q3 2016 and held it in 2 quarters. The position peaked at $266K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Corient Capital Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Corient Capital Partners sold 3,317 St Jude Medical shares in Q1 2017, an estimated $266K.
  • Corient Capital Partners first reported a position in St Jude Medical in Q3 2016 and held it in 2 quarters.
  • Corient Capital Partners's St Jude Medical position peaked at $266K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Corient Capital Partners's 13F filing for Q1 2017, filed 14 Aug 2017.